PSA Remains Excellent Tool, Despite Reports
The U.S. Preventive Services Task Force (USPSTF) recently recommended that healthy men should not receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening. If that government panel's recommendation is adopted, public and private insurance policies will stop paying for this vital test.
Every Physician at Advanced Urology Believes in PSA Testing
The PSA test provides early detection of irregularities that include an enlarged prostate or aggressive, fast-growing cancers. Thanks to early detection from a PSA test, 90 percent of all prostate cancers are now discovered before they spread. At this early stage, the survival rate is nearly 100 percent. Before PSA screening was available, 50 percent of newly diagnosed prostate cancer patients were diagnosed with metastatic disease—when cancer is no longer curable and treatment options are severely limited.